EDSA
Edesa Biotech, Inc.Company with tickers: EDSA
CIK
1540159
CUSIP
27966L306
Shares Outstanding
8,891,951
13F Activity (30d)
24 filings
24 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $3,891,815 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-6,638,377 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-6,466,001 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.78 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | — |